Concepedia

Publication | Open Access

Chemical Control of Quorum Sensing in <i>E. coli</i>: Identification of Small Molecule Modulators of SdiA and Mechanistic Characterization of a Covalent Inhibitor

26

Citations

47

References

2020

Year

Abstract

Enterohemorrhagic <i>Escherichia coli</i> (EHEC) is the causative agent of severe diarrheal disease in humans. Cattle are the natural reservoir of EHEC, and approximately 75% of EHEC infections in humans stem from bovine products. Many common bacterial pathogens, including EHEC, rely on chemical communication systems, such as quorum sensing (QS), to regulate virulence and facilitate host colonization. EHEC uses SdiA from <i>E. coli</i> (SdiA<sub>EC</sub>), an orphan LuxR-type receptor, to sense <i>N</i>-acyl l-homoserine lactone (AHL) QS signals produced by other members of the bovine enteric microbiome. SdiA<sub>EC</sub> regulates two phenotypes critical for colonizing cattle: acid resistance and the formation of attaching and effacing lesions. Despite the importance of SdiA<sub>EC</sub>, there is very little known about its selectivity for different AHL signals, and no chemical inhibitors that act specifically on SdiA<sub>EC</sub> have been reported. Such compounds would represent valuable tools to study the roles of QS in EHEC virulence. To identify chemical modulators of SdiA<sub>EC</sub> and delineate the structure-activity relationships (SARs) for AHL activity in this receptor, we report herein the screening of a focused library composed largely of AHLs and AHL analogues in an SdiA<sub>EC</sub> reporter assay. We describe the identity and SARs of potent modulators of SdiA<sub>EC</sub> activity, examine the promiscuity of SdiA<sub>EC</sub>, characterize the mechanism of a covalent inhibitor, and provide phenotypic assay data to support that these compounds can control SdiA<sub>EC</sub>-dependent acid resistance in <i>E. coli</i>. These SdiA<sub>EC</sub> modulators could be used to advance the study of LuxR-type receptor/ligand interactions, the biological roles of orphan LuxR-type receptors, and potential QS-based therapeutic approaches.

References

YearCitations

Page 1